Literature DB >> 9701027

The CMRF-35 mAb recognizes a second leukocyte membrane molecule with a domain similar to the poly Ig receptor.

B J Green1, G J Clark, D N Hart.   

Abstract

The CMRF-35 mAb recognizes an antigen found on most leukocytes including monocytes, neutrophils, macrophages, dendritic cells, and subpopulations of lymphocytes and bone marrow cells. A cDNA expressing the CMRF-35 epitope was isolated by expression cloning and this predicts for a type I cell surface glycoprotein belonging to the Ig superfamily. Here we demonstrate that the CMRF-35 mAb recognizes an epitope more widely distributed on hemopoietic cells and cell lines than suggested by expression analysis of the CMRF-35 mRNA. Furthermore, we have isolated a novel cDNA (CMRF-35-H9) that encodes a protein product also recognized by the CMRF-35 mAb. This cDNA product is a type I cell surface glycoprotein with a single Ig V-like domain. Although the sequences of the extracellular V-like domains of the two molecules are very similar, there is little similarity between the remainder of their sequences. The two transcripts are expressed independently of each other, and their presence accounts for the discrepancy between CMRF-35 mAb binding and mRNA analysis. The cytoplasmic tail of CMRF-35-H9 contains motifs similar to the inhibitory motifs found in some leukocyte surface receptors. Their expression in hemopoietic cells suggests that these two molecules may play distinct but related roles in the regulation of leukocyte function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701027     DOI: 10.1093/intimm/10.7.891

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

1.  Expression, crystallization and X-ray data collection from microcrystals of the extracellular domain of the human inhibitory receptor expressed on myeloid cells IREM-1.

Authors:  Nazzareno Dimasi; David Flot; Florine Dupeux; José A Márquez
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-02-13

Review 2.  The CD300 molecules: an emerging family of regulators of the immune system.

Authors:  Francisco Borrego
Journal:  Blood       Date:  2013-01-04       Impact factor: 22.113

3.  Extraordinary variation in a diversified family of immune-type receptor genes.

Authors:  N A Hawke; J A Yoder; R N Haire; M G Mueller; R T Litman; A L Miracle; T Stuge; L Shen; N Miller; G W Litman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

4.  CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines.

Authors:  Eun-Ju Kim; Sang-Min Lee; Kyoungho Suk; Won-Ha Lee
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

5.  All-trans-retinoic acid and Erk1/2 signaling synergistically regulate the expression of CD300B in human monocytic cells.

Authors:  Yong Wu; Qiuyan Chen; Tongkun Pai; A Catharine Ross
Journal:  Cell Immunol       Date:  2011-03-29       Impact factor: 4.868

6.  RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines.

Authors:  Bo Zhao; Seiji Maruo; Andrew Cooper; Michael R Chase; Eric Johannsen; Elliott Kieff; Ellen Cahir-McFarland
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

7.  The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells.

Authors:  Dikla Lankry; Tihana Lenac Rovis; Stipan Jonjic; Ofer Mandelboim
Journal:  Eur J Immunol       Date:  2013-06-21       Impact factor: 5.532

8.  CD300c is an activating receptor expressed on human monocytes.

Authors:  Venkateswara R Simhadri; John L Mariano; Aleksandra Gil-Krzewska; Qing Zhou; Francisco Borrego
Journal:  J Innate Immun       Date:  2013-04-06       Impact factor: 7.349

9.  Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a.

Authors:  K Grauwet; M Vitale; S De Pelsmaeker; T Jacob; K Laval; L Moretta; M Parodi; S Parolini; C Cantoni; H W Favoreel
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

10.  Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow.

Authors:  Eiji Umemoto; Toshiyuki Tanaka; Hidenobu Kanda; Soojung Jin; Kazuo Tohya; Kazuhiro Otani; Takahiro Matsutani; Masanori Matsumoto; Yukihiko Ebisuno; Myoung Ho Jang; Minoru Fukuda; Takako Hirata; Masayuki Miyasaka
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.